Cellvizio 100 series system with confocal Miniprobes
K-Number: K220477 · 2022-04-11
Device Summary
Frequently Asked Questions
What is the Cellvizio 100 series system with confocal Miniprobes?
Cellvizio 100 series system with confocal Miniprobes is a medical device that received FDA 510(k) clearance on 2022-04-11. The listed applicant is Mauna Kea Technologies. The 510(k) number is K220477.
When did Cellvizio 100 series system with confocal Miniprobes receive FDA 510(k) clearance?
Cellvizio 100 series system with confocal Miniprobes received FDA 510(k) clearance on 2022-04-11, under 510(k) number K220477.
Who is the listed applicant for Cellvizio 100 series system with confocal Miniprobes?
The FDA 510(k) record lists Mauna Kea Technologies as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Cellvizio 100 series system with confocal Miniprobes?
The FDA product code for Cellvizio 100 series system with confocal Miniprobes is OWN.
Other records listing Mauna Kea Technologies as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: OWN)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.